Literature DB >> 9662370

Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.

S Fleury1, R J de Boer, G P Rizzardi, K C Wolthers, S A Otto, C C Welbon, C Graziosi, C Knabenhans, H Soudeyns, P A Bart, S Gallant, J M Corpataux, M Gillet, P Meylan, P Schnyder, J Y Meuwly, W Spreen, M P Glauser, F Miedema, G Pantaleo.   

Abstract

We show that the fraction of proliferating CD4+ lymphocytes is similar in HIV-infected subjects in the early stage of disease and in HIV-negative subjects, whereas the fraction of proliferating CD8+ lymphocytes is increased 6.8-fold in HIV-infected subjects. After initiation of antiviral therapy, there is a late increase in proliferating CD4+ T cells associated with the restoration of CD4+ T-cell counts. These results provide strong support for the idea of limited CD4+ T-cell renewal in the early stage of HIV infection and indicate that after effective suppression of virus replication, the mechanisms of CD4+ T-cell production are still functional in early HIV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662370     DOI: 10.1038/nm0798-794

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  30 in total

Review 1.  Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy.

Authors:  G R Kaufmann; J Zaunders; D A Cooper
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

Review 2.  Current concepts in human immunodeficiency virus infection and AIDS.

Authors:  S A Schwartz; M P Nair
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy.

Authors:  E C Darcissac; V Vidal; X De La Tribonniere; Y Mouton; G M Bahr
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

4.  Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery.

Authors:  A E Sousa; A F Chaves; M Doroana; F Antunes; R M Victorino
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

5.  Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.

Authors:  R A Lempicki; J A Kovacs; M W Baseler; J W Adelsberger; R L Dewar; V Natarajan; M C Bosche; J A Metcalf; R A Stevens; L A Lambert; W G Alvord; M A Polis; R T Davey; D S Dimitrov; H C Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

6.  In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.

Authors:  H Blaak; A B van't Wout; M Brouwer; B Hooibrink; E Hovenkamp; H Schuitemaker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

7.  Normal physiology and HIV pathophysiology of human T-cell dynamics.

Authors:  D D Richman
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 8.  The role of cytokines in the pathogenesis and treatment of HIV infection.

Authors:  Marta Catalfamo; Cecile Le Saout; H Clifford Lane
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-26       Impact factor: 7.638

Review 9.  Targeting anti-HIV drugs to the CNS.

Authors:  Kavitha S Rao; Anuja Ghorpade; Vinod Labhasetwar
Journal:  Expert Opin Drug Deliv       Date:  2009-08       Impact factor: 6.648

Review 10.  The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications.

Authors:  C Fraser; N M Ferguson; F de Wolf; R M Anderson
Journal:  Proc Biol Sci       Date:  2001-10-22       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.